The Relationship Between Low-Density Lipoprotein Cholesterol Levels and the Incidence of Cardiovascular Disease in High-Risk Patients Treated With Pravastatin-Reference-Cited by-同舟云学术

The Relationship Between Low-Density Lipoprotein Cholesterol Levels and the Incidence of Cardiovascular Disease in High-Risk Patients Treated With Pravastatin

Published:2014 Issue:1 Volume:55 Page:39-47
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Daida Hiroyuki¹,Teramoto Tamio²,Kitagawa Yasuhisa³,Matsushita Yasuyuki⁴,Sugihara Masahiro⁴,

Affiliation:

1. Juntendo University School of Medicine

2. Teikyo University School of Medicine

3. Tokai University Hachioji Hospital

4. Daiichi Sankyo Co., Ltd.

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/55/1/55_13-002/_pdf

Reference42 articles.

1. 1. Asia Pacific Cohort Studies Collaboration. Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region. Circulation 2005; 112: 3384-90.

2. 2. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971; 74: 1-12.

3. 3. Wilhelmsen L. ESC Population Studies Lecture 1996. Cardiovascular monitoring of a city over 30 years. Eur Heart J 1997; 18: 1220-30.

4. 4. Scandinavian Simvas Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.

5. 5. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-7.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal lipid-lowering therapy in patients who were functionally deferred percutaneous coronary intervention;Scientific Reports;2023-07-05

2. High Apolipoprotein E Levels Predict Adverse Limb Events in Patients with Peripheral Artery Disease Due to Peripheral Artery Disease Undergoing Endovascular Treatment and On-Statin Treatment;International Heart Journal;2021-07-30

3. Defining apolipoprotein B treatment targets;Nigerian Journal of Clinical Practice;2019

4. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017;Journal of Atherosclerosis and Thrombosis;2018-09-01

5. Pharmacological treatment for dyslipidemia;Journal of the Japanese Coronary Association;2018